- /
- Supported exchanges
- / US
- / FBRX.NASDAQ
Forte Biosciences Inc (FBRX NASDAQ) stock market data APIs
Forte Biosciences Inc Financial Data Overview
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Forte Biosciences Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Forte Biosciences Inc data using free add-ons & libraries
Get Forte Biosciences Inc Fundamental Data
Forte Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -76 902 000
- Earnings Per Share: -4
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-04-01
- EPS/Forecast: -1.16
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Forte Biosciences Inc News
New
5 Undervalued Stocks That Soared: SION +277%, FBRX +306%, NKTR +869% & More
(RTTNews) - "The secret to investing is to figure out the value of something - and then pay a lot less", according to Joel Greenblatt, an American investor, hedge fund manager, and author of The Littl...
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watch
(RTTNews) - Today's top biotech gainers include Virax Biolabs, following its agreement with Fosun Diagnostics; Forte Biosciences, after reporting positive vitiligo data; Connect Biopharma, with a key ...
Enovix, Forte Biosciences rally premarket; PepsiCo slips
Investing.com - U.S. stock index futures were mixed on Thursday as investors weighed escalating tensions between the United States and Iran against a continued rebound in semiconductor shares. By 07:...
Top Midday Gainers
Ares Management (ARES) on Thursday agreed to acquire real estate investment trust Whitestone REIT (W PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.